Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;75(3):125-135.
doi: 10.1038/s41429-021-00497-0. Epub 2022 Jan 12.

Post translational modifications of Trifolitoxin: a blue fluorescent peptide antibiotic

Affiliations

Post translational modifications of Trifolitoxin: a blue fluorescent peptide antibiotic

Benjamin J Lethbridge et al. J Antibiot (Tokyo). 2022 Mar.

Abstract

Trifolitoxin (TFX, C41H63N15O15S) is a selective, ribosomally-synthesized, post-translationally modified, peptide antibiotic, produced by Rhizobium leguminosarum bv. trifolii T24. TFX specifically inhibits α-proteobacteria, including the plant symbiont Rhizobium spp., the plant pathogen Agrobacterium spp. and the animal pathogen Brucella abortus. TFX-producing strains prevent legume root nodulation by TFX-sensitive rhizobia. TFX has been isolated as a pair of geometric isomers, TFX1 and TFX2, which are derived from the biologically inactive primary amino acid sequence: Asp-Ile-Gly-Gly-Ser-Arg-Gln-Gly-Cys-Val-Ala. Gly-Cys is present as a thiazoline ring and the Arg-Gln-Gly sequence is extensively modified to a UV absorbing, blue fluorescent chromophore. The chromophore consists of a conjugated, 5-membered heterocyclic ring and side chain of modified glutamine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Unmodified TFX peptide with the results of the chemical analyses of the biologically active TFX peptide
Fig. 2
Fig. 2
Structure of TFX in aqueous solution

References

    1. Schwinghamer EA, Belkengren RP. Inhibition of rhizobia by a strain of Rhizobium trifolii: some properties of the antibiotic and strain. Arch Microbiol. 1968;64:130–45. - PubMed
    1. Triplett EW, Barta TM. Trifolitoxin production and nodulation are necessary for the expression of superior nodulation competiveness by Rhizobium leguminosarum bv. trifolii strain T24 on clover. Plant Physiol. 1987;85:3810–4. - PMC - PubMed
    1. Triplett EW. Isolation of genes involved in nodulation competitiveness from Rhizobium leguminosarum bv. trifolii T24. Proc Natl Acad Sci USA. 1988;85:3810–4. - PMC - PubMed
    1. Triplett EW, Breil BT, Splitter GA. Expression of tfx and sensitivity to the Rhizobial peptide antibiotic trifolitoxin in a taxonomically distinct group of α-proteobacteria including the animal pathogen Brucella abortus. Appl Environ Microbiol. 1994;60:4163–6. - PMC - PubMed
    1. Robleto EA, Kmiecik K, Oplinger ES, Nienhis J, Triplett EW. Trifolitoxin production increases nodulation competiveness of Rhizobium elti CE3 under agricultural conditions. Appl Environ Microbiol. 1998;64:2630–3. - PMC - PubMed

Publication types

MeSH terms